These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7098447)

  • 21. Stereospecific radioimmunoassay of alpha-l-acetylmethadol (LAAM).
    McGilliard KL; Olsen GD
    J Pharmacol Exp Ther; 1980 Oct; 215(1):205-12. PubMed ID: 7452485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Uptake and efflux of 1-alpha-acetylmethadol (LAAM) and methadone in the isolated perfused rat lung.
    Roerig DL; Dawson CA; Wang RI
    Drug Metab Dispos; 1982; 10(3):230-5. PubMed ID: 6125355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of enterohepatic circulation in the analgesic action of 1-alpha-acetylmethadol in the rat.
    Roerig DL; Hasegawa AT; Wang RI
    Drug Metab Dispos; 1979; 7(5):306-9. PubMed ID: 40771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simultaneous determination of acetylmethadol and its active riotransformation products in human biofluids.
    Kaiko RF; Chatterjie N; Inturrisi CE
    J Chromatogr; 1975 Jun; 109(2):247-58. PubMed ID: 1150818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of phenobarbital pretreatment on the plasma and urinary levels of (-)-alpha-acetylmethadol and its metabolites.
    Kuttab SH; Nowshad F; Shargel L
    J Pharm Sci; 1985 Mar; 74(3):331-4. PubMed ID: 4009444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cumulation of active metabolites of levo-alpha-acetylmethadol in the rat fetus and neonate.
    Lichtblau L; Finkle BS; Sparber SB
    Life Sci; 1982 Jan; 30(3):307-12. PubMed ID: 7070211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discriminative stimulus properties of levo-alpha-acetylmethadol and its metabolites.
    Holtzman SG
    Pharmacol Biochem Behav; 1979 Apr; 10(4):565-8. PubMed ID: 461484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolism of methadone and levo-alpha-acetylmethadol (LAAM) by human intestinal cytochrome P450 3A4 (CYP3A4): potential contribution of intestinal metabolism to presystemic clearance and bioactivation.
    Oda Y; Kharasch ED
    J Pharmacol Exp Ther; 2001 Sep; 298(3):1021-32. PubMed ID: 11504799
    [TBL] [Abstract][Full Text] [Related]  

  • 29. l-Alpha-acetylmethadol (LAAM): prognostic considerations.
    Resnick RB; Orlin L; Geyer G; Schuyten-Resnick E; Kestenbaum RS; Freedman AM
    Am J Psychiatry; 1976 Jul; 133(7):814-9. PubMed ID: 937573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discriminative stimulus effects of l-alpha-acetylmethadol (LAAM), buprenorphine and methadone in morphine-treated rhesus monkeys.
    Brandt MR; Cabansag SR; France CP
    J Pharmacol Exp Ther; 1997 Aug; 282(2):574-84. PubMed ID: 9262317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical experiences with 959 opioid-dependent patients treated with levo-alpha-acetylmethadol (LAAM).
    Tennant FS; Rawson RA; Pumphrey E; Seecof R
    J Subst Abuse Treat; 1986; 3(3):195-202. PubMed ID: 3806733
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of levo-alpha-acetylmethadol and its metabolites on schedule-controlled behavior in the pigeon.
    McGivney WT; McMillan DE
    J Pharmacol Exp Ther; 1981 Feb; 216(2):299-305. PubMed ID: 7463351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extraction method and thin-layer chromatographic system for the determination of alpha-l-acetylmethadol and metabolites in biological fluids.
    Kuttab SH; North-Root H; Henderson GL
    J Chromatogr; 1976 Feb; 117(1):193-8. PubMed ID: 175076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early clinical studies of levo-alpha acetylmethadol (LAAM): an opiate for use in the medical treatment of chronic heroin dependence.
    Blaine JD
    NIDA Res Monogr; 1978; (19):249-59. PubMed ID: 106289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determination of acetylmethadol and metabolites by use of high-performance liquid chromatography.
    Kiang CH; Campos-Flor S; Inturrisi CE
    J Chromatogr; 1981 Jan; 222(1):81-93. PubMed ID: 7217329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of cellular tolerance to lethality and analgesia concurrent with physical dependence following repeated oral administration of LAAM.
    Masten LW
    Drug Alcohol Depend; 1979 Sep; 4(5):381-90. PubMed ID: 574449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 1-alpha-acetylmethadol(LAAM) pharmacokinetics and metabolism: current status.
    Misra AL; Mulé SJ
    Am J Drug Alcohol Abuse; 1975; 2(3-4):301-5. PubMed ID: 818895
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmacokinetics and metabolism of (-)-alpha-[2-3H]acetylmethadol (LAAM) in the monkey: evidence for a new metabolite.
    Misra AL; Vardy J; Bloch R; Mulé SJ; Deneau GA
    J Pharm Pharmacol; 1976 Apr; 28(4):316-8. PubMed ID: 6726
    [No Abstract]   [Full Text] [Related]  

  • 39. The binding of LAAM and its metabolites to blood constituents.
    Toro-Goyco E; Martin BR; Harris LS
    NIDA Res Monogr; 1979; 27():54-60. PubMed ID: 95037
    [No Abstract]   [Full Text] [Related]  

  • 40. The quantitative analysis of 1-alpha-acetylmethadol and its principal metabolites in biological specimens by gas chromatography-chemical ionization-multiple ion monitoring mass spectrometry.
    Jennison TA; Finkle BS; Chinn DM; Crouch DJ
    J Chromatogr Sci; 1979 Feb; 17(2):64-74. PubMed ID: 479337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.